HopeStage
Back to all studies
RecruitingNCT06341517

Active or sham cerebellar stimulation for apathy in schizophrenia

About this titleRead the official source — NCT06341517
Device studyAges 18–65Switzerland
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Geneva and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 15, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
70
Sponsor
Indrit Begue
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Switzerland
Age range
From 18 Years to 65 Years
Official registry ID
NCT06341517
Official title
Show the full official title

Brain Circuitry Therapeutics for Schizophrenia - A Cross-species Longitudinal Randomized Controlled Clinical Study to Treat Negative Symptoms of Schizophrenia Using Non-invasive Stimulation of the Cerebellum

Recruitment & locations

Currently recruiting

Geneva

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Indrit Begue.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies